PHARMADES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMADES
Largest movements
- Cash -€254,367
down €254,367 (-57.9%), from €439,049 to €184,682
mainly Receivables within one year (-€173,992) and Investment in fixed assets (net) (-€153,330)
- Receivables within one year +€173,992
up €173,992 (+43.9%), from €396,318 to €570,310
of which Other amounts receivable: +€246,081
- Tangible fixed assets +€120,670
up €120,670 (+34.1%), from €353,889 to €474,559
of which Furniture and vehicles: +€105,041
- Stocks and contracts -€23,160
down €23,160 (-12.2%), from €190,055 to €166,895
- Profit (loss) carried forward +€73,394
up €73,394 (+6.7%), from €1.1m to €1.2m
- Trade debts -€47,766
down €47,766 (-27.1%), from €176,021 to €128,255
- Gross operating margin -€107,793
down €107,793 (-30.2%), from €357,463 to €249,670
- Taxes -€29,286
down €29,286 (-53.3%), from €54,909 to €25,623
- Depreciation +€17,055
up €17,055 (+109.3%), from €15,605 to €32,660
- Staff costs -€9,667
down €9,667 (-7.4%), from €129,804 to €120,137
- Financial income +€4,255
up €4,255 (+171.4%), from €2,482 to €6,737
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,380,537 | €1,396,536 | +€15,999 | +1.2% |
| Fixed assets | 21/28 | €353,979 | €474,649 | +€120,670 | +34.1% |
| Tangible fixed assets | 22/27 | €353,889 | €474,559 | +€120,670 | +34.1% |
| Land and buildings | 22 | €343,826 | €334,902 | -€8,924 | -2.6% |
| Plant, machinery and equipment | 23 | €8,641 | €33,194 | +€24,553 | +284.2% |
| Furniture and vehicles | 24 | €1,422 | €106,463 | +€105,041 | +7387.1% |
| Financial fixed assets | 28 | €90 | €90 | = | 0.0% |
| Current assets | 29/58 | €1,026,558 | €921,887 | -€104,671 | -10.2% |
| Stocks and contracts in progress | 3 | €190,055 | €166,895 | -€23,160 | -12.2% |
| Stocks | 30/36 | €190,055 | €166,895 | -€23,160 | -12.2% |
| Amounts receivable within one year | 40/41 | €396,318 | €570,310 | +€173,992 | +43.9% |
| Trade receivables | 40 | €161,198 | €89,109 | -€72,089 | -44.7% |
| Other amounts receivable | 41 | €235,121 | €481,201 | +€246,081 | +104.7% |
| Cash at bank and in hand | 54/58 | €439,049 | €184,682 | -€254,367 | -57.9% |
| Deferred charges and accrued income | 490/1 | €1,136 | €0 | -€1,136 | -100.0% |
| Total equity and liabilities | 10/49 | €1,380,537 | €1,396,536 | +€15,999 | +1.2% |
| Equity | 10/15 | €1,179,171 | €1,252,565 | +€73,394 | +6.2% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Capital | 10 | €75,000 | €75,000 | = | 0.0% |
| Issued capital | 100 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €7,500 | €7,500 | = | 0.0% |
| Non-distributable reserves | 130/1 | €7,500 | €7,500 | = | 0.0% |
| Legal reserve | 130 | €7,500 | €7,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,096,671 | €1,170,065 | +€73,394 | +6.7% |
| Amounts payable | 17/49 | €201,366 | €143,971 | -€57,396 | -28.5% |
| Amounts payable within one year | 42/48 | €201,366 | €143,971 | -€57,396 | -28.5% |
| Trade debts | 44 | €176,021 | €128,255 | -€47,766 | -27.1% |
| Suppliers | 440/4 | €176,021 | €128,255 | -€47,766 | -27.1% |
| Taxes, remuneration and social security | 45 | €25,345 | €15,716 | -€9,629 | -38.0% |
| Taxes | 450/3 | €9,629 | €0 | -€9,629 | -100.0% |
| Remuneration and social security | 454/9 | €15,716 | €15,716 | = | 0.0% |
| Non-recurring operating income | 76A | - | €28,926 | +€28,926 | |
| Remuneration, social security and pensions | 62 | €129,804 | €120,137 | -€9,667 | -7.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,605 | €32,660 | +€17,055 | +109.3% |
| Other operating charges | 640/8 | €3,202 | €3,031 | -€171 | -5.4% |
| Gross operating margin | 9900 | €357,463 | €249,670 | -€107,793 | -30.2% |
| Operating profit (loss) | 9901 | €208,851 | €93,842 | -€115,009 | -55.1% |
| Financial income | 75/76B | €2,482 | €6,737 | +€4,255 | +171.4% |
| Recurring financial income | 75 | €2,482 | €6,737 | +€4,255 | +171.4% |
| Financial charges | 65/66B | €1,696 | €1,562 | -€134 | -7.9% |
| Recurring financial charges | 65 | €1,696 | €1,562 | -€134 | -7.9% |
| Profit (loss) for the period before taxes | 9903 | €209,637 | €99,017 | -€110,620 | -52.8% |
| Income taxes | 67/77 | €54,909 | €25,623 | -€29,286 | -53.3% |
| Profit (loss) for the period | 9904 | €154,728 | €73,394 | -€81,334 | -52.6% |
| Profit (loss) for the period to be appropriated | 9905 | €154,728 | €73,394 | -€81,334 | -52.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.